FDA selects 6 more meds for speedy review

The six new drugs awarded FDA Commissioner's National Priority Vouchers brings to 15 the total number of therapies selected for the new pilot program. Under this program, the FDA says the standard 10- to 12-month review time could be shaved down to "within months."

Editor's Pick

Top Story FDA Adds 6 More Meds to Pilot Program for Speedy Review of Drugs in the National Interest The six new drugs awarded FDA Commissioner's National Priority Vouchers brings to 15 the total number of therapies selected for the new pilot program. Under this program, the FDA says the standard 10- to 12-month review time could be shaved down to "within months." Sponsored RCM Outsourcing: Balancing Human Expertise & Smart Technology Presented by Greenway Health Greenway Health blends smart technology with human expertise to elevate revenue cycle. Learn More.

Featured News

Carrum Health Expands SUD Treatment Program to Include Nearly All Substances Carrum Health has expanded its value-based substance use program to include cannabis, sedatives and stimulants. How One Company Aims to Fix the Prosthetic Fitting Process HumoTech has developed a robotic platform that lets patients quickly try multiple prosthetic or exoskeleton options in a clinic, using both objective data and patient feedback to identify the best fit. The technology aims to reduce device abandonment and improve outcomes. MedCity FemFwd: Inside Wellcome Leap and Pivotal's $100M Commitment To Women's Health In this episode, we're joined by Dr. Renee Wittemyer, vice president of program strategy at Pivotal Ventures, and Dr. Regina Dugan, CEO of Wellcome Leap. They discuss the organizations' recent $100 million commitment to accelerate women's health research. StartUPDATES: New Developments from Healthcare Startups Check out news from Oral Genome, Amae Health, Hepta, and more. Reimbursing Your Digital Twin: A New Era In Patient-Specific Surgery Deploying AI-driven segmentation at an enterprise level goes beyond operational efficiency. It signals a commitment to pioneering the next era of precision healthcare. Optimizing Care Pathways: The Next Frontier in Rehab Performance Care pathways are, in essence, the maps we follow to get patients from where they are to where they want to be. However, many rehab care plans are still too fragmented, too reactive, and too disconnected from the broader ecosystem of care. This won't cut it in this next phase of transformation.

Video   Video: How AI Is Tackling Administrative Burdens There is no question that EHRs have created major administrative burdens, noted Nikhil Buduma, CEO of Ambience Healthcare.  These systems are causing clinicians to spend most of their time on documentation and billing work instead of connecting with patients. Buduma said Ambience aims to solve this by integrating AI directly into EHR workflows to automate tasks before, during and after the visit. The goal is to remove non-clinical work so clinicians can focus on the patient in front of them and restore joy in practicing medicine.

Resources

Debunked Episode 21: The Drug Price Debate, AI in Healthcare Companies Face Consolidation But How Much? How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are working with the Trump administration to lower costs? View Now

MedCity News • PO Box 901 • New York, NY unsubscribe